Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients

Transplantation

Volumn 65, Issue 4, 1998, Pages 505-510

  Cole, E ^a   Keown, P ^a   Landsberg, D ^a   Halloran, P ^a   Shoker, A ^a   Rush, D ^a   Jeffrey, J ^a   Russell, D ^a   Stiller, C ^a   Muirhead, N ^a   Paul, L ^a   Zaltzman, J ^a   Loertscher, R ^a   Daloze, P ^a   Dandavino, R ^a   Boucher, A ^a   Handa, P ^a   Lawen, J ^a   Belitsky, P ^a   Parfrey, P ^a   Tan, A ^a   Hendricks, L ^a   more..

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; CANADA; COMMUNICABLE DISEASES; CYCLOSPORINE; EMULSIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TIME FACTORS; TISSUE DONORS;

EID: 0032570644     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802270-00009     Document Type: Article

References (13)